ABEONA THERAPEUTICS INC. Financial Ratios
ABEO|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
44.7%
Profit Margin
1223.1%
Net Income / Revenue
Asset Turnover
0.03
Revenue / Total Assets
Equity Multiplier
1.38
Total Assets / Equity
Composite: 44.7% (reported: 44.7%)
Profitability
Liquidity
Current Ratio
6.93
Quick Ratio
6.74
Solvency
Interest Coverage
-20.41
Efficiency
Asset Turnover
0.03
Inventory Turnover
0.28
Days Sales Outstanding
386 days
As of FY2025 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
+89.8%
+105.6pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.